Artivion (AORT) Stock: Buy, Sell, or Hold?
AORT - Artivion, Inc.
$22.90
-0.19 (-0.82%)
▼
5d:
+6.36%
30d:
-5.1%
90d:
-8.4%
HOLD
MODERATE Confidence
Analysis Updated: Oct 21, 2026 12:00 AM ET
Earnings: Nov 05, 2026
13d
Get Alerted When AORT Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
📊 HOLD: AORT shows mixed signals. Fine to hold existing positions. Not urgent to buy or sell.
📊 HOLD: AORT shows mixed signals. Fine to hold existing positions. Not urgent to buy or sell.
Long-Term Wealth Forecast (2031)
Based on Analyst Consensus Growth & Historical Valuation
0% (Stagnation)
50% (Hyper Growth)
EST. PRICE IN 2031
$36.43
Based on 14.5% avg growth
INTRINSIC VALUE TODAY
$22.62
Trading above historical range
How this is calculated: We use a Growth Decay Model: starting with analyst consensus growth (adjusted above) and gradually slowing it down to a long-term terminal rate (4%) by Year 5. This provides a more realistic valuation than assuming constant hyper-growth. We then apply a 25.0x Exit PE.
In-depth Analysis How we analyze
Valuation Analysis: AORT is currently trading at $22.90, which is considered fair relative to its 30-day fair value range of $21.63 to $23.90. From a valuation perspective, the stock is trading at a discount (Forward PE: 30.6) compared to its historical average (36.3). Remarkably, the market is currently pricing in an annual earnings decline of 5.6% over the next few years. This aligns with recent fundamental challenges.
Technical Outlook: Technically, AORT is showing sideways momentum. Immediate support is located at $20.21, while resistance sits at $23.69.
Market Sentiment: The stock scores a mixed 52/100 on our bottoming-setup gauge, with only partial signs of a stabilized entry point. In the options market, Implied Volatility is low (0th percentile), suggesting options premiums are relatively cheap. This makes it an attractive time for long options strategies if you have a directional bias. Wall Street analysts see significant upside, with an average price target of $42.15 (+84.1%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Technical Outlook: Technically, AORT is showing sideways momentum. Immediate support is located at $20.21, while resistance sits at $23.69.
Market Sentiment: The stock scores a mixed 52/100 on our bottoming-setup gauge, with only partial signs of a stabilized entry point. In the options market, Implied Volatility is low (0th percentile), suggesting options premiums are relatively cheap. This makes it an attractive time for long options strategies if you have a directional bias. Wall Street analysts see significant upside, with an average price target of $42.15 (+84.1%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Quick Decision Summary
Current Position
FAIR
Historical Trading Range
$21.63 -
$23.90
Company Quality Score
54/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
77.7%
Protect Your Profits
Holding AORT? Use our AI-powered strategies to protect your downside while keeping your long-term position.
View Profit Protection PlanAll Signals
- NEUTRAL: Price in fair range
- BULLISH: Options cheap (IV 0th percentile)
- NEUTRAL: Mixed technical signals (52/100)
- BULLISH: High volume confirmation
- BULLISH: Trading 84.1% below Wall St target ($42.15)
- NEUTRAL: Bottoming setup forming (52/100) — watch for confirmation
Trading Range Analysis
30-Day Trading Range
$21.63 -
$23.90
Current vs Trading Range
FAIR
Expected Move (7 Days)
±$1.94
(8.5%)
Support & Resistance Levels
Support Level
$20.21
Resistance Level
$23.69
Current Trend
Sideways
Technical data as of
Oct 21, 2026
Fundamental Context
Forward P/E (Next Year Est.)
30.60
Wall Street Target
$42.15
(+84.1%)
Revenue Growth (YoY)
11.3%
Profit Margin
-0.7%
Valuation Discount vs History
-5.6% cheaper
PE vs Historical
30.6 vs 36.3
CHEAP
Market-Implied Price Targets
If current PE multiple persists
Implied Growth (YoY):
-5.6%
(market-implied from PE analysis)
1-Year Target
$21.62
(-6%)
2-Year Target
$20.41
(-11%)
3-Year Target
$19.26
(-16%)
3-Yr Target (if PE normalizes)
(PE: 31→36)
$22.85
(0%)
3-Year Scenarios
Using analyst projected EPS growth
Bull:
(PE: 30.6, Growth: 88.0%)
$77.29
(+238%)
Base:
(SPY PE: 19.9, Growth: 88.0%)
$50.16
(+119%)
Bear:
(PE: 16.9, Growth: 88.0%)
$42.63
(+86%)
💡
Upside Surprise Potential
If earnings stabilize (0% growth), PE could expand from 30.6 to 36.3
Stabilization Target:
$27.16
(+18.6%)
PE Expansion Potential:
+18.6%
Share & Embed Analysis
Last updated: October 21, 2026 8:22 PM ET
Data refreshes hourly during market hours. Next update: 9:22 PM
Data refreshes hourly during market hours. Next update: 9:22 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is AORT showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Medical Devices Stocks
Top-rated stocks in Medical Devices by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
DXCM
DexCom Inc |
STRONG BUY
29 analysts |
$96 | 50 HOLD |
|
BSX
Boston Scientific Corp |
STRONG BUY
31 analysts |
$59 | 50 HOLD |
|
MDT
Medtronic PLC |
BUY
29 analysts |
$105 | 43 HOLD |
|
AXGN
Axogen Inc |
STRONG BUY
12 analysts |
$54 | 75 BUY |
|
TNDM
Tandem Diabetes Care Inc |
BUY
25 analysts |
$28 | 54 HOLD |
Advanced AORT Option Strategies
Professional options setups generated by AI based on today's AORT price and gamma walls.
